{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT03715933",
            "orgStudyIdInfo": {
                "id": "Ph1 INBRX-109"
            },
            "organization": {
                "fullName": "Inhibrx Biosciences, Inc",
                "class": "INDUSTRY"
            },
            "briefTitle": "Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas",
            "officialTitle": "An Open-Label, Multicenter, First-in-Human, Phase 1 Dose-Escalation and Multicohort Expansion Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas",
            "therapeuticArea": [
                "Oncology and Hematology",
                "Other"
            ],
            "study": "phase-study-of-inbrx-in-subjects-with-locally-advanced-or-metastatic-solid-tumors-including-sarcomas"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-04",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2018-10-10",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-12",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-07",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2018-10-11",
            "studyFirstSubmitQcDate": "2018-10-19",
            "studyFirstPostDateStruct": {
                "date": "2018-10-23",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-04-24",
            "lastUpdatePostDateStruct": {
                "date": "2024-04-25",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Inhibrx Biosciences, Inc",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This is a first-in-human, open-label, non-randomized, three-part phase 1 trial of INBRX-109, which is a recombinant humanized tetravalent antibody targeting the human death receptor 5 (DR5)."
        },
        "conditionsModule": {
            "conditions": [
                "Solid Tumors",
                "Malignant Pleural Mesothelioma",
                "Gastric Adenocarcinoma",
                "Colorectal Adenocarcinoma",
                "Sarcoma",
                "Pancreatic Adenocarcinoma",
                "Ewing Sarcoma",
                "Chondrosarcoma",
                "GIST",
                "SDH-deficient Solid Tumors"
            ],
            "keywords": [
                "Phase 1",
                "Phase 1 Clinical Trial",
                "Solid Tumors",
                "Sarcoma",
                "Pleural Mesothelioma",
                "Stomach Cancer",
                "Colorectal Cancer",
                "Colon Cancer",
                "Rectal Cancer",
                "DR5",
                "Gastric Adenocarcinoma",
                "Colorectal Adenocarcinoma",
                "Pancreatic Adenocarcinoma",
                "Ewing Sarcoma",
                "Chondrosarcoma"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "SEQUENTIAL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 240,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Dose Escalation",
                    "type": "EXPERIMENTAL",
                    "description": "INBRX-109 will be escalated (3+3 design) in subjects with locally advanced or metastatic solid tumors including sarcomas.",
                    "interventionNames": [
                        "Drug: INBRX-109"
                    ]
                },
                {
                    "label": "Expansion Malignant Pleural Mesothelioma",
                    "type": "EXPERIMENTAL",
                    "description": "Subjects with malignant pleural mesothelioma will be treated with single-agent INBRX-109 at either the MTD or RP2D.",
                    "interventionNames": [
                        "Drug: INBRX-109"
                    ]
                },
                {
                    "label": "Expansion Gastric Adenocarcinoma",
                    "type": "EXPERIMENTAL",
                    "description": "Subjects with gastric adenocarcinoma will be treated with single-agent INBRX-109 at either the MTD or RP2D.",
                    "interventionNames": [
                        "Drug: INBRX-109"
                    ]
                },
                {
                    "label": "Expansion Colorectal Adenocarcinoma",
                    "type": "EXPERIMENTAL",
                    "description": "Subjects with colorectal (CRC) adenocarcinoma will be treated with single-agent INBRX-109 at either the MTD or RP2D.",
                    "interventionNames": [
                        "Drug: INBRX-109"
                    ]
                },
                {
                    "label": "Expansion Sarcomas",
                    "type": "EXPERIMENTAL",
                    "description": "Subjects with certain sarcoma subtypes will be treated with single-agent INBRX-109 at either the MTD or RP2D.",
                    "interventionNames": [
                        "Drug: INBRX-109"
                    ]
                },
                {
                    "label": "Combination Expansion Malignant Pleural Mesothelioma",
                    "type": "EXPERIMENTAL",
                    "description": "Subjects with malignant pleural mesothelioma will be treated with INBRX-109 in combination with chemotherapies (carboplatin, cisplatin, carboplatin and pemetrexed, or cisplatin and pemetrexed)",
                    "interventionNames": [
                        "Drug: INBRX-109",
                        "Drug: Carboplatin",
                        "Drug: Cisplatin",
                        "Drug: Pemetrexed"
                    ]
                },
                {
                    "label": "Combination Expansion Pancreatic Adenocarcinoma",
                    "type": "EXPERIMENTAL",
                    "description": "Subjects with pancreatic adenocarcinoma will be treated with INBRX-109 in combination with 5FU/irinotecan based chemotherapy",
                    "interventionNames": [
                        "Drug: INBRX-109",
                        "Drug: 5-fluorouracil",
                        "Drug: Irinotecan"
                    ]
                },
                {
                    "label": "Combination Expansion Ewing Sarcoma",
                    "type": "EXPERIMENTAL",
                    "description": "Subjects with Ewing Sarcoma will be treated with INBRX-109 in combination with irinotecan and temozolomide",
                    "interventionNames": [
                        "Drug: INBRX-109",
                        "Drug: Irinotecan",
                        "Drug: Temozolomide"
                    ]
                },
                {
                    "label": "Combination Expansion Colorectal Adenocarcinoma",
                    "type": "EXPERIMENTAL",
                    "description": "Subjects with colorectal adenocarcinoma will be treated with INBRX-109 in combination with FOLFIRI based chemotherapy",
                    "interventionNames": [
                        "Drug: INBRX-109",
                        "Drug: 5-fluorouracil",
                        "Drug: Irinotecan"
                    ]
                },
                {
                    "label": "Expansion Solid Tumors",
                    "type": "EXPERIMENTAL",
                    "description": "Subjects with Solid tumors and high BMI will be treated with single-agent INBRX-109 at either the MTD or RP2D.",
                    "interventionNames": [
                        "Drug: INBRX-109"
                    ]
                },
                {
                    "label": "Combination Expansion SDH-deficient solid tumors or GIST",
                    "type": "EXPERIMENTAL",
                    "description": "Subjects with SDH-deficient solid tumors or GIST will be treated with INBRX-109 in combination with temozolomide",
                    "interventionNames": [
                        "Drug: INBRX-109",
                        "Drug: Temozolomide"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "INBRX-109",
                    "description": "Tetravalent DR5 Agonist Antibody",
                    "armGroupLabels": [
                        "Combination Expansion Colorectal Adenocarcinoma",
                        "Combination Expansion Ewing Sarcoma",
                        "Combination Expansion Malignant Pleural Mesothelioma",
                        "Combination Expansion Pancreatic Adenocarcinoma",
                        "Combination Expansion SDH-deficient solid tumors or GIST",
                        "Dose Escalation",
                        "Expansion Colorectal Adenocarcinoma",
                        "Expansion Gastric Adenocarcinoma",
                        "Expansion Malignant Pleural Mesothelioma",
                        "Expansion Sarcomas",
                        "Expansion Solid Tumors"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Carboplatin",
                    "description": "Chemotherapy",
                    "armGroupLabels": [
                        "Combination Expansion Malignant Pleural Mesothelioma"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Cisplatin",
                    "description": "Chemotherapy",
                    "armGroupLabels": [
                        "Combination Expansion Malignant Pleural Mesothelioma"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Pemetrexed",
                    "description": "Chemotherapy",
                    "armGroupLabels": [
                        "Combination Expansion Malignant Pleural Mesothelioma"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "5-fluorouracil",
                    "description": "Chemotherapy",
                    "armGroupLabels": [
                        "Combination Expansion Colorectal Adenocarcinoma",
                        "Combination Expansion Pancreatic Adenocarcinoma"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Irinotecan",
                    "description": "Chemotherapy",
                    "armGroupLabels": [
                        "Combination Expansion Colorectal Adenocarcinoma",
                        "Combination Expansion Ewing Sarcoma",
                        "Combination Expansion Pancreatic Adenocarcinoma"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Temozolomide",
                    "description": "Chemotherapy",
                    "armGroupLabels": [
                        "Combination Expansion Ewing Sarcoma",
                        "Combination Expansion SDH-deficient solid tumors or GIST"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Frequency and severity of adverse events of INBRX-109",
                    "description": "Adverse events will be assessed and severity assigned by using the National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE), version 5.0.",
                    "timeFrame": "Up to 2 years"
                },
                {
                    "measure": "Maximum Tolerated Dose (MTD) and/or Recommended Phase 2 Dose (RP2D) of INBRX-109",
                    "description": "The MTD and/or RP2D of INBRX-109 will be determined.",
                    "timeFrame": "Up to 2 years"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Area under the serum concentration time curve (AUC) of INBRX-109",
                    "description": "Area under the serum concentration time curve (AUC) of INBRX-109 will be determined.",
                    "timeFrame": "Up to 2 years"
                },
                {
                    "measure": "Immunogenicity of INBRX-109",
                    "description": "Frequency of ant-drug antibodies (ADA) against INBRX-109 will be determined.",
                    "timeFrame": "Up to 2 years"
                },
                {
                    "measure": "Maximum observed serum concentration (Cmax) of INBRX-109",
                    "description": "Maximum observed serum concentration (Cmax) of INBRX-109 will be determined.",
                    "timeFrame": "Up to 2 years"
                },
                {
                    "measure": "Trough observed serum concentration (Ctrough) of INBRX-109",
                    "description": "Trough observed serum concentration (Cmax) of INBRX-109 will be determined.",
                    "timeFrame": "Up to 2 years"
                },
                {
                    "measure": "Time to Cmax (Tmax) of INBRX-109",
                    "description": "Time to Cmax (Tmax) of INBRX-109 will be determined.",
                    "timeFrame": "Up to 2 years"
                }
            ],
            "otherOutcomes": [
                {
                    "measure": "Anti-tumor activity of INBRX-109",
                    "description": "Tumor response will be determined by RECISTv1.1.",
                    "timeFrame": "Up to 2 years"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Males or females aged \u226512 to \\<85 years for Ewing sarcoma and 18 to \\<85 years of age for GIST.\n* Escalation: Histologically or cytologically-confirmed advanced/metastatic or non-resectable solid tumors, including sarcoma, that are refractory or intolerant to standard therapy, or for which no standard therapy exists that is likely to confer any clinical benefit.\n* Expansion Cohorts: Malignant pleural mesothelioma, gastric adenocarcinoma, colorectal adenocarcinoma, pancreatic adenocarcinoma and certain sarcoma subtypes (e.g., chondrosarcoma, Ewing sarcoma), GIST, and SDH-def solid tumors with locally advanced or metastatic, non-resectable disease, that are refractory or intolerant to standard therapy, or for which no standard therapy exists that is likely to confer any clinical benefit.\n* Measurable disease as defined by RECISTv1.1 (or modified RECIST for mesothelioma) criteria.\n* Adequate hematologic, coagulation, hepatic and renal function as defined per protocol.\n* Eastern Cooperative Oncology Group performance status (ECOG PS) of 0 or 1 for Part 1 and ECOG PS of 0, 1 or 2 for Parts 2 and 3.\n\nExclusion Criteria:\n\n* Prior treatment with or exposure to DR5 agonists.\n* Receipt of any anticancer therapy (including investigational agents) within 4 weeks or within 5 half-lives prior to the first dose of study treatment. Exceptions per protocol.\n* Receipt of radiotherapy within 4 weeks prior to the first dose of study treatment, and liver-directed within 12 months prior to the first dose of study drug.\n* Subject has undergone allogeneic hematopoietic stem cell or bone marrow transplantation within the last 5 years. Exception: Participants who have had a stem cell or bone marrow transplant \\> 5 years ago are eligible for enrollment, as long as there are no symptoms of graft-versus-host disease (GVHD).\n* Prior or concurrent malignancies. Exception: Subjects with a prior or concurrent malignancy whose natural history or treatment does not have the potential to interfere with the safety or efficacy assessments of INBRX-109.\n* Hematologic malignancies.\n* Symptomatic active primary CNS tumors, leptomeningeal disease, and CNS metastases. Exceptions per protocol.\n* Chronic liver disease including but not limited to cirrhosis, non-alcoholic fatty liver disease (NAFLD) or non-alcoholic steatohepatitis (NASH), alcohol-related liver disease, hemochromatosis, Wilson's disease, alpha-1 antitrypsin deficiency, multiple liver hemangioma (except incidental finding of clinically nonsignificant liver hemangioma), hepatic or biliary autoimmune disorders (ie, primary biliary cholangitis, autoimmune hepatitis), history of portal or hepatic vein thrombosis, and sinusoidal occlusion syndrome. Exceptions per protocol.\n* Acute viral or toxic liver disease within 12 months prior to the first dose of study drug.\n* Evidence or history of hepatitis B, hepatitis C, or human immunodeficiency virus (HIV) infection.\n* Clinically significant cardiac condition, including myocardial infarction, uncontrolled angina, cerebrovascular accident, or other acute uncontrolled heart disease \\< 3 months;\n* Sensitivity or contraindications to INBRX-109, irinotecan, or temozolomide.\n* Major surgery within 4 weeks prior to enrollment on this trial.\n* Systemic infection requiring antibiotics within 2 weeks prior to the first dose of study drug.\n* Pregnant or nursing females.\n* Patients who are receiving strong cytochrome P450 (CYP) 3A inhibitors and/or inducers, and/or UGT1A1 inhibitors within 14 days of Cycle 1 Day 1.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "12 Years",
            "maximumAge": "85 Years",
            "stdAges": [
                "CHILD",
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Study Director, -Inhibrx",
                    "role": "CONTACT",
                    "phone": "858-500-7833",
                    "email": "clinicaltrials@inhibrx.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Clinical Lead",
                    "affiliation": "Inhibrx Biosciences, Inc",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "HonorHealth Research Institute",
                    "status": "ACTIVE_NOT_RECRUITING",
                    "city": "Scottsdale",
                    "state": "Arizona",
                    "zip": "85258",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 33.50921,
                        "lon": -111.89903
                    }
                },
                {
                    "facility": "City of Hope",
                    "status": "RECRUITING",
                    "city": "Duarte",
                    "state": "California",
                    "zip": "91010",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Anahita Nersiseyan Malhami",
                            "role": "CONTACT",
                            "phone": "818-726-2563",
                            "email": "anersiseyan@coh.org"
                        },
                        {
                            "name": "New Patient Services Coordinator",
                            "role": "CONTACT",
                            "phone": "1-800-826-4673",
                            "email": "newpatientref@coh.org"
                        },
                        {
                            "name": "Mark Agulnik, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.13945,
                        "lon": -117.97729
                    }
                },
                {
                    "facility": "Valkyrie Clinical Trials",
                    "status": "RECRUITING",
                    "city": "Los Angeles",
                    "state": "California",
                    "zip": "90067",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Leila Mirtagui",
                            "role": "CONTACT",
                            "email": "leila.mirtagui@valkyrieclinicaltrials.com"
                        },
                        {
                            "name": "David Berz, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.05223,
                        "lon": -118.24368
                    }
                },
                {
                    "facility": "University of California, San Diego (UCSD) - Moores Cancer Center",
                    "status": "RECRUITING",
                    "city": "San Diego",
                    "state": "California",
                    "zip": "92093",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Adam Burgoyne, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.71533,
                        "lon": -117.15726
                    }
                },
                {
                    "facility": "Sarcoma Oncology Center",
                    "status": "RECRUITING",
                    "city": "Santa Monica",
                    "state": "California",
                    "zip": "90403",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Victoria Chua-Alcala",
                            "role": "CONTACT",
                            "phone": "310-552-9999",
                            "email": "vchua@sarcomaoncology.com"
                        },
                        {
                            "name": "Sant P Chawla, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.01945,
                        "lon": -118.49119
                    }
                },
                {
                    "facility": "University of Colorado Hospital",
                    "status": "RECRUITING",
                    "city": "Aurora",
                    "state": "Colorado",
                    "zip": "80045",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Trace Dimos",
                            "role": "CONTACT",
                            "email": "trace.dimos@cuanschutz.edu"
                        },
                        {
                            "name": "Christopher Lieu, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.72943,
                        "lon": -104.83192
                    }
                },
                {
                    "facility": "Emory University - Winship Cancer Institute",
                    "status": "RECRUITING",
                    "city": "Atlanta",
                    "state": "Georgia",
                    "zip": "30322",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Suzanne Scott",
                            "role": "CONTACT",
                            "phone": "404-778-4083"
                        },
                        {
                            "name": "Olatunji Alese, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.749,
                        "lon": -84.38798
                    }
                },
                {
                    "facility": "The University of Chicago",
                    "status": "ACTIVE_NOT_RECRUITING",
                    "city": "Chicago",
                    "state": "Illinois",
                    "zip": "60637",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 41.85003,
                        "lon": -87.65005
                    }
                },
                {
                    "facility": "Center for Cancer Research at NCI",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Bethesda",
                    "state": "Maryland",
                    "zip": "20892",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "J Glod",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.98067,
                        "lon": -77.10026
                    }
                },
                {
                    "facility": "University of Michigan",
                    "status": "RECRUITING",
                    "city": "Ann Arbor",
                    "state": "Michigan",
                    "zip": "48109",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Myron Hepner",
                            "role": "CONTACT",
                            "email": "mhepner@med.umich.edu"
                        },
                        {
                            "name": "Rashmi Chugh, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.27756,
                        "lon": -83.74088
                    }
                },
                {
                    "facility": "START Midwest Michigan, PC",
                    "status": "ACTIVE_NOT_RECRUITING",
                    "city": "Grand Rapids",
                    "state": "Michigan",
                    "zip": "49546",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 42.96336,
                        "lon": -85.66809
                    }
                },
                {
                    "facility": "David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center",
                    "status": "RECRUITING",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10021",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Care Advisors",
                            "role": "CONTACT",
                            "phone": "833-675-5437"
                        },
                        {
                            "name": "Emily Slotkin, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                },
                {
                    "facility": "Cleveland Clinic",
                    "status": "RECRUITING",
                    "city": "Cleveland",
                    "state": "Ohio",
                    "zip": "44195",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Jessica Grebenc",
                            "role": "CONTACT",
                            "email": "grebenj@ccf.org"
                        },
                        {
                            "name": "Dale Shepard, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.4995,
                        "lon": -81.69541
                    }
                },
                {
                    "facility": "Oregon Health & Science University",
                    "status": "RECRUITING",
                    "city": "Portland",
                    "state": "Oregon",
                    "zip": "97239",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Sarah Tressel",
                            "role": "CONTACT",
                            "phone": "503-494-0824",
                            "email": "tressel@ohsu.edu"
                        },
                        {
                            "name": "Michael Heinrich, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 45.52345,
                        "lon": -122.67621
                    }
                },
                {
                    "facility": "University of Pennsylvania Abramson Cancer Center",
                    "status": "RECRUITING",
                    "city": "Philadelphia",
                    "state": "Pennsylvania",
                    "zip": "19106",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Sarcoma Research",
                            "role": "CONTACT",
                            "email": "SarcomaResearch@uphs.upenn.edu"
                        },
                        {
                            "name": "Lee Hartner, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.95233,
                        "lon": -75.16379
                    }
                },
                {
                    "facility": "Vanderbilt University School of Medicine",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Nashville",
                    "state": "Tennessee",
                    "zip": "37232",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Elizabeth Davis, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 36.16589,
                        "lon": -86.78444
                    }
                },
                {
                    "facility": "UT MD Anderson Cancer Center",
                    "status": "RECRUITING",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77030",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Jihyun Shin",
                            "role": "CONTACT",
                            "phone": "713-792-6934",
                            "email": "jishin@mdanderson.org"
                        },
                        {
                            "name": "Anna Lui",
                            "role": "CONTACT",
                            "phone": "713-792-4843",
                            "email": "ALui@mdanderson.org"
                        },
                        {
                            "name": "David Hong, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                },
                {
                    "facility": "NEXT Oncology",
                    "status": "ACTIVE_NOT_RECRUITING",
                    "city": "San Antonio",
                    "state": "Texas",
                    "zip": "78229",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 29.42412,
                        "lon": -98.49363
                    }
                },
                {
                    "facility": "NEXT Oncology - Virginia",
                    "status": "RECRUITING",
                    "city": "Fairfax",
                    "state": "Virginia",
                    "zip": "22031",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Kayla Grossi",
                            "role": "CONTACT",
                            "email": "kgrossi@nextoncology.com;"
                        },
                        {
                            "role": "CONTACT",
                            "email": "NXTVIR_Coordinators@nextoncology.com"
                        },
                        {
                            "name": "Alexander Spira, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.84622,
                        "lon": -77.30637
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000000230",
                    "term": "Adenocarcinoma"
                },
                {
                    "id": "D000012509",
                    "term": "Sarcoma"
                },
                {
                    "id": "D000008654",
                    "term": "Mesothelioma"
                },
                {
                    "id": "D000086002",
                    "term": "Mesothelioma, Malignant"
                },
                {
                    "id": "D000012512",
                    "term": "Sarcoma, Ewing"
                },
                {
                    "id": "D000002813",
                    "term": "Chondrosarcoma"
                }
            ],
            "ancestors": [
                {
                    "id": "D000002277",
                    "term": "Carcinoma"
                },
                {
                    "id": "D000009375",
                    "term": "Neoplasms, Glandular and Epithelial"
                },
                {
                    "id": "D000009370",
                    "term": "Neoplasms by Histologic Type"
                },
                {
                    "id": "D000018204",
                    "term": "Neoplasms, Connective and Soft Tissue"
                },
                {
                    "id": "D000000236",
                    "term": "Adenoma"
                },
                {
                    "id": "D000018301",
                    "term": "Neoplasms, Mesothelial"
                },
                {
                    "id": "D000008175",
                    "term": "Lung Neoplasms"
                },
                {
                    "id": "D000012142",
                    "term": "Respiratory Tract Neoplasms"
                },
                {
                    "id": "D000013899",
                    "term": "Thoracic Neoplasms"
                },
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000010997",
                    "term": "Pleural Neoplasms"
                },
                {
                    "id": "D000008171",
                    "term": "Lung Diseases"
                },
                {
                    "id": "D000012140",
                    "term": "Respiratory Tract Diseases"
                },
                {
                    "id": "D000012516",
                    "term": "Osteosarcoma"
                },
                {
                    "id": "D000018213",
                    "term": "Neoplasms, Bone Tissue"
                },
                {
                    "id": "D000009372",
                    "term": "Neoplasms, Connective Tissue"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M3585",
                    "name": "Adenocarcinoma",
                    "asFound": "Adenocarcinoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M15327",
                    "name": "Sarcoma",
                    "asFound": "Sarcoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M15330",
                    "name": "Sarcoma, Ewing",
                    "asFound": "Ewing Sarcoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M6053",
                    "name": "Chondrosarcoma",
                    "asFound": "Chondrosarcoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M16064",
                    "name": "Stomach Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M9495",
                    "name": "Hematoma, Subdural",
                    "relevance": "LOW"
                },
                {
                    "id": "M11634",
                    "name": "Mesothelioma",
                    "asFound": "Mesothelioma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M2537",
                    "name": "Mesothelioma, Malignant",
                    "asFound": "Malignant Pleural Mesothelioma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5534",
                    "name": "Carcinoma",
                    "relevance": "LOW"
                },
                {
                    "id": "M12320",
                    "name": "Neoplasms, Glandular and Epithelial",
                    "relevance": "LOW"
                },
                {
                    "id": "M12315",
                    "name": "Neoplasms by Histologic Type",
                    "relevance": "LOW"
                },
                {
                    "id": "M20350",
                    "name": "Neoplasms, Connective and Soft Tissue",
                    "relevance": "LOW"
                },
                {
                    "id": "M3591",
                    "name": "Adenoma",
                    "relevance": "LOW"
                },
                {
                    "id": "M20445",
                    "name": "Neoplasms, Mesothelial",
                    "relevance": "LOW"
                },
                {
                    "id": "M11172",
                    "name": "Lung Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M14979",
                    "name": "Respiratory Tract Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M16658",
                    "name": "Thoracic Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M13887",
                    "name": "Pleural Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M11168",
                    "name": "Lung Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14977",
                    "name": "Respiratory Tract Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M15334",
                    "name": "Osteosarcoma",
                    "relevance": "LOW"
                },
                {
                    "id": "M20359",
                    "name": "Neoplasms, Bone Tissue",
                    "relevance": "LOW"
                },
                {
                    "id": "M12317",
                    "name": "Neoplasms, Connective Tissue",
                    "relevance": "LOW"
                },
                {
                    "id": "T5284",
                    "name": "Soft Tissue Sarcoma",
                    "asFound": "Sarcoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "T2148",
                    "name": "Ewing Sarcoma",
                    "asFound": "Ewing Sarcoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "T1172",
                    "name": "Chondrosarcoma",
                    "asFound": "Chondrosarcoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "T5486",
                    "name": "Stomach Cancer",
                    "relevance": "LOW"
                },
                {
                    "id": "T3584",
                    "name": "Malignant Mesothelioma",
                    "asFound": "Mesothelioma",
                    "relevance": "HIGH"
                },
                {
                    "id": "T4340",
                    "name": "Osteosarcoma",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC06",
                    "name": "Digestive System Diseases"
                },
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                },
                {
                    "abbrev": "BC14",
                    "name": "Heart and Blood Diseases"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "BC26",
                    "name": "Wounds and Injuries"
                },
                {
                    "abbrev": "BC08",
                    "name": "Respiratory Tract (Lung and Bronchial) Diseases"
                },
                {
                    "abbrev": "BC17",
                    "name": "Skin and Connective Tissue Diseases"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000016190",
                    "term": "Carboplatin"
                },
                {
                    "id": "D000005472",
                    "term": "Fluorouracil"
                },
                {
                    "id": "D000077146",
                    "term": "Irinotecan"
                },
                {
                    "id": "D000068437",
                    "term": "Pemetrexed"
                },
                {
                    "id": "D000077204",
                    "term": "Temozolomide"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000970",
                    "term": "Antineoplastic Agents"
                },
                {
                    "id": "D000000963",
                    "term": "Antimetabolites"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000000964",
                    "term": "Antimetabolites, Antineoplastic"
                },
                {
                    "id": "D000007166",
                    "term": "Immunosuppressive Agents"
                },
                {
                    "id": "D000007155",
                    "term": "Immunologic Factors"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000059004",
                    "term": "Topoisomerase I Inhibitors"
                },
                {
                    "id": "D000059003",
                    "term": "Topoisomerase Inhibitors"
                },
                {
                    "id": "D000004791",
                    "term": "Enzyme Inhibitors"
                },
                {
                    "id": "D000005493",
                    "term": "Folic Acid Antagonists"
                },
                {
                    "id": "D000019384",
                    "term": "Nucleic Acid Synthesis Inhibitors"
                },
                {
                    "id": "D000018906",
                    "term": "Antineoplastic Agents, Alkylating"
                },
                {
                    "id": "D000000477",
                    "term": "Alkylating Agents"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M18650",
                    "name": "Carboplatin",
                    "asFound": "System",
                    "relevance": "HIGH"
                },
                {
                    "id": "M1692",
                    "name": "Temozolomide",
                    "asFound": "Cervical",
                    "relevance": "HIGH"
                },
                {
                    "id": "M1671",
                    "name": "Irinotecan",
                    "asFound": "Related",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4225",
                    "name": "Antibodies",
                    "relevance": "LOW"
                },
                {
                    "id": "M8600",
                    "name": "Fluorouracil",
                    "asFound": "According",
                    "relevance": "HIGH"
                },
                {
                    "id": "M264",
                    "name": "Pemetrexed",
                    "asFound": "Target",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10184",
                    "name": "Immunoglobulins",
                    "relevance": "LOW"
                },
                {
                    "id": "M6182",
                    "name": "Cisplatin",
                    "relevance": "LOW"
                },
                {
                    "id": "M4281",
                    "name": "Antimetabolites",
                    "relevance": "LOW"
                },
                {
                    "id": "M10212",
                    "name": "Immunosuppressive Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M10201",
                    "name": "Immunologic Factors",
                    "relevance": "LOW"
                },
                {
                    "id": "M29349",
                    "name": "Topoisomerase I Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M29348",
                    "name": "Topoisomerase Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M7951",
                    "name": "Enzyme Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M17546",
                    "name": "Vitamin B Complex",
                    "relevance": "LOW"
                },
                {
                    "id": "M8618",
                    "name": "Folic Acid",
                    "relevance": "LOW"
                },
                {
                    "id": "M8619",
                    "name": "Folic Acid Antagonists",
                    "relevance": "LOW"
                },
                {
                    "id": "M20942",
                    "name": "Antineoplastic Agents, Alkylating",
                    "relevance": "LOW"
                },
                {
                    "id": "M3820",
                    "name": "Alkylating Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "T120",
                    "name": "Cola",
                    "relevance": "LOW"
                },
                {
                    "id": "T446",
                    "name": "Folic Acid",
                    "relevance": "LOW"
                },
                {
                    "id": "T447",
                    "name": "Folinic Acid",
                    "relevance": "LOW"
                },
                {
                    "id": "T448",
                    "name": "Folate",
                    "relevance": "LOW"
                },
                {
                    "id": "T475",
                    "name": "Vitamin B9",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "Micro",
                    "name": "Micronutrients"
                },
                {
                    "abbrev": "Hemat",
                    "name": "Hematinics"
                },
                {
                    "abbrev": "HB",
                    "name": "Herbal and Botanical"
                },
                {
                    "abbrev": "Vi",
                    "name": "Vitamins"
                }
            ]
        }
    },
    "hasResults": false
}